Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Expert Review of Clinical Pharmacology|August 31, 2019
Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancerNoah Federman, Ray McDermottEuropean Journal of Cancer (Oxford, England : 1990)|May 11, 2010
The emerging pathogenic and therapeutic importance of the anaplastic lymphoma kinase geneFergal C Kelleher, Ray McDermottJournal of Biomedicine & Biotechnology|April 11, 2003
Gene Therapy Applications to Cancer TreatmentSusy M. Scholl, Silke Michaelis, Ray McDermottIrish Journal of Medical Science|November 10, 2023
Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world dataKarine Ronan, Emmet Jordan, Christine Leonard, et al.Clinical Breast Cancer|August 8, 2009
Metastatic phyllodes tumor causing small-bowel obstructionRonan J Kelly, Ciara Barrett, Niall Swan, et al.Frontiers in Medicine|April 5, 2024
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategiesAnna Linehan, Mary O'Reilly, Ray McDermott, et al.Expert Review of Anticancer Therapy|October 15, 2010
Challenges of drug resistance in the management of pancreatic cancerRizwan Sheikh, Naomi Walsh, Martin Clynes, et al.Frontiers in Medicine|November 11, 2024
Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancerNeal Shore, Joan Carles, Ray McDermott, et al.Diagnostics (Basel, Switzerland)|March 6, 2021
Diagnostic Strategies for Treatment Selection in Advanced Prostate CancerCiara S McNevin, Anne-Marie Baird, Ray McDermott, et al.Carcinogenesis|July 25, 2013
Fibroblast growth factor receptors, developmental corruption and malignant diseaseFergal C Kelleher, Hazel O'Sullivan, Elizabeth Smyth, et al.Pageof 10